Table 1.
Element | Relative frequency of histidine prototrophy with indicated inhibitor
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No inhibitor | 8 Cl-TIBO
|
TBZ
|
|||||||||||
0 | 5 μm | 10 μm | 20 μm | 40 μm | 80 μm | 0 | 5 μm | 10 μm | 20 μm | 40 μm | 80 μm | ||
Ty | 2.9 (±1.9) × 10−2 | 1.0 | 1.06 | 0.85 | 1.24 | 0.92 | 1.28 | 1.0 | 0.88 | 1.01 | 0.90 | 0.98 | 0.97 |
HART | 1.1 (±0.8) × 10−3 | 1.0 | 0.35 | 0.25 | 0.11 | 0.05 | 0.02 | 1.0 | 0.30 | 0.25 | 0.14 | 0.04 | 0.01 |
L100I | 4.4 (±3.2) × 10−4 | 1.0 | 0.93 | 1.13 | 0.98 | 0.86 | 0.55 | 1.0 | 0.71 | 0.64 | 0.25 | 0.23 | 0.12 |
Y181C | 1.4 (±0.8) × 10−4 | 1.0 | 0.88 | 1.0 | 1.03 | 0.90 | 0.58 | 1.0 | 0.88 | 1.0 | 1.03 | 0.90 | 0.58 |
The frequency of RT-mediated histidine prototrophy was determined for Ty and hybrid Ty/HIV elements after brief induction of expression. The frequency of RT-mediated events is shown in the “No inhibitor” column. The frequency of RT-mediated histidine prototrophy was determined for Ty and hybrid Ty/HIV elements in the presence and absence of 8 Cl-TIBO and TBZ. The frequencies for each element-inhibitor combination are expressed relative to the frequency of the element in the absence of inhibtor (no inhibtor = 1.0).